Shares of Cepheid rose 7.4 percent for the five-day trading period ended Tuesday. The firm’s stock closed up nearly 6 percent for Tuesday alone following a presentation by CEO John Bishop at the Piper Jaffray Health Care Conference in New York (see related article, this issue). 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.